BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

AI/ML

Biotechnology

Pharmaceutical

Therapeutics

BigHat Bio

Mark DePristo

Randy Schreckhise

Vi Vu

Abiy Seifu

John Corbin

Mitchell Stieg

Leslie Grab

Danielle Landrein

Timothy Park

Charbel Eid

Eddie Abrams

Liz Schwarzbach

Peyton Greenside

The Directors Team at BigHat Bio is responsible for setting strategic direction, overseeing key operational functions, and ensuring the integration of advanced machine learning with experimental platforms. This team plays a critical role in aligning departmental goals with BigHat's mission to revolutionize antibody therapeutics, driving innovation and efficiency in the development of next-generation treatments.

Directors Team

Research Team

Software Development Team

Advisory Team

Directors Team

About

Team members

Other teams at BigHat Bio

Research Team

Software Development Team

Advisory Team